Experiences in supporting the structured collection of cancer nanotechnology data using caNanoLab

Summary The cancer Nanotechnology Laboratory (caNanoLab) data portal is an online nanomaterial database that allows users to submit and retrieve information on well-characterized nanomaterials, including composition, in vitro and in vivo experimental characterizations, experimental protocols, and related publications. Initiated in 2006, caNanoLab serves as an established resource with an infrastructure supporting the structured collection of nanotechnology data to address the needs of the cancer biomedical and nanotechnology communities. The portal contains over 1,000 curated nanomaterial data records that are publicly accessible for review, comparison, and re-use, with the ultimate goal of accelerating the translation of nanotechnology-based cancer therapeutics, diagnostics, and imaging agents to the clinic. In this paper, we will discuss challenges associated with developing a nanomaterial database and recognized needs for nanotechnology data curation and sharing in the biomedical research community. We will also describe the latest version of caNanoLab, caNanoLab 2.0, which includes enhancements and new features to improve usability such as personalized views of data and enhanced search and navigation.

[1]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[2]  H. Bartsch,et al.  International Agency for Research on Cancer. , 1969, WHO chronicle.

[3]  Eric G. Campbell,et al.  Codifying Collegiality: Recent Developments in Data Sharing Policy in the Life Sciences , 2014, PloS one.

[4]  Bengt Fadeel,et al.  Broaden the discussion. , 2013, Nature nanotechnology.

[5]  Peter N. Robinson,et al.  Genomic data sharing for translational research and diagnostics , 2014, Genome Medicine.

[6]  Vasiliki Demas,et al.  T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood , 2013, Science Translational Medicine.

[7]  Kevin A. Henry,et al.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.

[8]  Jason E. Stewart,et al.  Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.

[9]  Nastassja A. Lewinski,et al.  Nanocuration workflows: Establishing best practices for identifying, inputting, and sharing data to inform decisions on nanomaterials , 2015, Beilstein journal of nanotechnology.

[10]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Michelle Bradbury,et al.  Cancer nanomedicines: closing the translational gap , 2014, The Lancet.

[12]  Bill Bynum,et al.  Lancet , 2015, The Lancet.

[13]  Hilary S. Leeds,et al.  Data use under the NIH GWAS Data Sharing Policy and future directions , 2014, Nature Genetics.

[14]  Robert Rallo,et al.  An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology , 2015, Beilstein journal of nanotechnology.

[15]  Stephanie A. Morris,et al.  caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine. , 2013, Computational science & discovery.

[16]  Juli D. Klemm,et al.  caNanoLab: A nanomaterial data repository for biomedical research , 2014, 2014 IEEE International Conference on Bioinformatics and Biomedicine (BIBM).

[17]  Martin Fritts,et al.  ISA-TAB-Nano: A Specification for Sharing Nanomaterial Research Data in Spreadsheet-based Format , 2013, BMC Biotechnology.

[18]  Jeliazkova Nina,et al.  Summary of the Spring 2014 NSC Database Survey , 2014 .

[19]  Nathan A. Baker,et al.  NanoParticle Ontology for cancer nanotechnology research , 2011, J. Biomed. Informatics.